A Rare Case of Gastrointestinal Amyloidosis Due to Monoclonal Gammopathy of Undetermined Significance.
| Autor: | Singh S; Internal Medicine, Camden Clark Medical Center, Parkersburg, USA., Gopireddy G; Internal Medicine, Camden Clark Medical Center, Parkersburg, USA., Naum S; Gastroenterology, Camden Clark Medical Center, Parkersburg, USA., Iannetti MP; Internal Medicine, Camden Clark Medical Center, Parkersburg, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Apr 21; Vol. 15 (4), pp. e37953. Date of Electronic Publication: 2023 Apr 21 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.37953 |
| Abstrakt: | Amyloidosis of the gastrointestinal (GI) tract is caused by the deposition of fibrils made of serum proteins into extracellular spaces. It is an uncommon disease with a poor prognosis, requiring prompt diagnosis and treatment. Treatment for amyloid light chain (AL)-type amyloidosis involves supportive care as well as addressing any underlying plasma cell dyscrasias. We present the case of a 64-year-old female diagnosed with AL-type GI amyloidosis with associated monoclonal gammopathy of undetermined significance. Unfortunately, the treatment was initiated nine months after the initial presentation, and she died one month later. Awareness of GI amyloidosis may allow for faster diagnosis and treatment in future patients. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Singh et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|